***** TODAY’S NEWS AstraZeneca still waiting for the upside of MedImmune acquisition. Pfizer: More Lipitor, fewer heart complications - A reanalysis of research data found a high dose of popular …
Today’s Top Three in Pharma 030409
Teva's Copaxone approved for preventative treament of MS - The drug is already approved to treat relapsing-remitting multiple sclerosis, where new symptoms occur suddenly or older symptoms become …